Skip to main content
BCS
NYSE Finance

Barclays Q3: £2.3bn PBT, 11.7% RoTE, New £500m Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Positive
Importance info
8
Price
$22.51
Mkt Cap
$74.741B
52W Low
$19.49
52W High
$28.685
52W Position info
15% above low
Off High info
22% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

BCS sits 15% above its 52-week low of $19.49.

Summary

Barclays posted Q3 profit before tax of £2.3bn (up 12%) and 11.7% RoTE, declared a new £500m buyback taking 2026 distributions to £2.8bn, and said it is on track for all 2026 targets.


Key Events · Earnings and Guidance · BCS

  • Q3 Profit Before Tax Up 12%

    Q326 profit before tax was £2.3bn versus £2.1bn a year earlier, on income of £7.4bn (up 3%). For Q326 YTD, profit before tax reached £8,388m against £7,280m in Q325 YTD.

  • New £500m Buyback Announced

    A new £500m tranche brings 2026 year-to-date announced distributions to £2.8bn, up 46% year-on-year, against a plan to return at least £10bn between 2024 and 2026.

  • Returns and Capital Position

    Q326 RoTE was 11.7% and Q326 YTD RoTE 13.8%, with EPS of 12.3p for the quarter (up 18%). The CET1 ratio was 14.2%, or 14.0% including the new buyback, inside the 13-14% target range.

  • Cost Actions and FY26 Guidance

    Q326 structural cost actions were £201m versus £93m in Q325, with a further c.£300m planned in Q426. Group total costs are guided to c.£18.5bn in FY26 and c.£18.4bn in FY27.


Analysis · BCS · Finance

Profit before tax rose 12% to £2.3bn on income of £7.4bn, with return on tangible equity at 11.7% for the quarter and 13.8% year-to-date. Management says all 2026 targets have been met or are on track, and the 2028 goals were reaffirmed. A new £500m buyback lifts year-to-date announced distributions to £2.8bn, up 46% year-on-year, while the CET1 ratio of 14.2% sits at the top of the 13-14% target range. Offsetting that: a weaker FICC franchise (down 19% year-on-year) and restructuring costs — £201m of structural cost actions in the quarter, another c.£300m planned for Q4, and total costs guided to c.£18.5bn for FY26. Basel 3.1 takes effect on 1 January 2027, adding £8-15bn of RWAs (30-55bps of CET1) but cutting the MDA requirement to 11.6%.

How filings like this one have moved

In the 30 days to Oct 22, 2026, 36.8% of the 1026 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.78%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BCS was trading at $22.51 on NYSE in the Finance sector, with a market capitalization of approximately $74.7B. The 52-week trading range was $19.49 to $28.69. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BCS - Latest Insights

BCS
Oct 22, 2026, 4:20 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $22.63
Real-time Price: $22.51 info
Change: -$0.120 (-0.53%) info
Market Cap: $74.741B info
BCS
Oct 01, 2026, 4:50 PM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $23.52
Real-time Price: $22.51 info
Change: -$1.01 (-4%) info
Market Cap: $74.741B info
BCS
Jul 28, 2026, 11:40 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $26.91
Real-time Price: $22.51 info
Change: -$4.40 (-16%) info
Market Cap: $74.741B info
BCS
Jul 28, 2026, 7:56 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $26.74
Real-time Price: $22.51 info
Change: -$4.23 (-16%) info
Market Cap: $74.741B info
BCS
Jul 01, 2026, 7:54 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $26.87
Real-time Price: $22.51 info
Change: -$4.36 (-16%) info
Market Cap: $74.741B info